March 10, 2020

What is TRexit?

March 10, 2020/ Jeremy Grummet

Screen Shot 2020-01-16 at 1.08.21 pm.png

Australia has been leading the world in its practice of performing prostate biopsy via the skin (Transperineal Biopsy) instead of via the rectum (Transrectal). Movember’s Prostate Cancer Outcomes Registry shows that in Victoria, the majority of prostate biopsies are now performed via the skin. In 2013, it was only 5%.

There are 2 major advantages to patients. Our research has shown that the sepsis rate when performing prostate biopsy via the skin is zero or near zero. This is in contrast to the increasing rates of sepsis from transrectal biopsy we are seeing worldwide.

Secondly, no antibiotics are needed for Transperineal biopsy. This makes the wider community safer, as it avoids the promotion of multi-resistant bacteria (superbugs).

The world is taking notice, with the switch from Transrectal to Transperineal prostate biopsy - TRexit - gaining momentum. Here’s an article I wrote with leaders in this field from around the world to raise awareness and advocate for patient safety: https://go.nature.com/3cmimWm

May 25, 2015

No more stabbing in the dark!

May 25, 2015/ Jeremy Grummet

Having just returned from speaking at the world’s largest urology conference in New Orleans, the American Urology Association’s Annual Meeting, it’s clear that the blind transrectal ultrasound-guided (TRUS) biopsy will thankfully soon be a thing of the past....

A safer way to biopsy the prostate

September 19, 2014/ Jeremy Grummet

Dr Grummet was invited to write this article as a guest blog on Adelaide Urologist Dr Nicholas Brook’s website in February 2014.

What’s wrong with the current standard method of prostate biopsy?
What is transperineal biopsy, and why is it safer?
Are there any downsides to the transperineal approach?
Is it as good as TRUS at cancer detection?
What other advantage might TP biopsy provide?